B · Normal
[Beijing Xiantong International Pharmaceutical Technology Co., Ltd.-B passed the Hong Kong Stock Exchange listing hearing] On October 28, Livermore Securities showed that Beijing Xiantong International Pharmaceutical Technology Co., Ltd.-B updated the post-hearing information set, which means that the company’s Hong Kong Stock Exchange IPO passed the hearing.
Hong Kong stock IPO news 🕐 2026-10-28 21:59

Related telegraphs

Comments

0/500
Captcha (click to refresh)
No comments yet